“The term refers to companies that are selling a product or solution targeted to a single condition, such as headaches or diabetes or pregnancy.” This post considers the market for these employer-paid and patient-focused services. ~ learn more
“A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells1. She is the first person with the disease to be treated using cells that were extracted […]
“The data supports the hypothesis that light, which suppresses or shifts central circadian rhythms, putting them in an “abnormal phase”, may also change how insulin is secreted and glucose metabolized.” ~ learn more
The PHTI is a new independant nonprofit that, “aims to provide independent, evidence-based assessments of emerging products, something that is currently lacking in the market.” Their first “blistering” report concluded that diabetes monitoring apps “do not deliver meaningful clinical benefits, […]
Researchers from Illinois did, and then they created it. The first mass-market insulin came from livestock. Nowadays it’s largely made by bacteria in reactors. Maybe (long shot) things will go full circle back to livestock? “An unassuming brown bovine from […]
“Canadian medical researchers trained the machine-learning AI to recognise 14 vocal differences in the voice of someone with type 2 diabetes compared to someone without diabetes. The auditory features that the AI focussed on included slight changes in pitch and […]
Here’s a doozy: “But a physician utilizing diet alone to achieve remission in a patient with type 2 diabetes is penalized financially because, when the risk is adjusted, diabetes is no longer listed among the patient’s conditions. So, Medicare pays […]
“Abbott CEO Robert Ford has said he expects the consumer devices to contribute to the company’s goal of $10 billion in sales for its Libre business by 2028.” ~ learn more
In another, more recent, experiment with human hookworm species Necator americanus, researchers found that “lowered HOMA-IR values indicated that people were experiencing considerable improvements in insulin sensitivity – results that were both clinically and statistically significant.” ~ learn more
This article from AARP covers the increasing adoption of this technology for wellness rather than diabetes management. It’s relatively balanced. ~ learn more